XML 13 R5.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Common Stock
Class A Common stock
IPO [Member]
Common Stock
Class A Common stock
Private Placement [Member]
Common Stock
Class A Common stock
Common Stock
Class B Common stock
Private Placement [Member]
Common Stock
Class B Common stock
Additional Paid-in Capital
IPO [Member]
Additional Paid-in Capital
Private Placement [Member]
Additional Paid-in Capital
Accumulated Deficit
IPO [Member]
Private Placement [Member]
Total
Balance at the beginning at Dec. 31, 2020     $ 7   $ 3     $ 101,080 $ (80,259)     $ 20,831
Balance at the beginning (in shares) at Dec. 31, 2020     7,091,960   3,134,162              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Proceeds from stock option exercises               26       26
Proceeds from stock option exercises (in shares)     3,305                  
Proceeds from sale of common stock through Employee Stock Purchase Plan               208       208
Proceeds from sale of common stock through Employee Stock Purchase Plan (in shares)     27,244                  
Issuance of common stock, net of issuance costs   $ (2)   $ (1)     $ (13,750)       $ (13,753)  
Issuance of common stock, net of issuance costs (in shares)   2,122,637   1,179,244                
Stock-based compensation               3,535       3,535
Net loss                 (24,832)     (24,832)
Balance at the ending at Dec. 31, 2021     $ 9   $ 4     118,599 (105,091)     13,521
Balance at the ending (in shares) at Dec. 31, 2021     9,245,146   4,313,406              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Proceeds from stock option exercises               78       78
Proceeds from stock option exercises (in shares)     13,887                  
Additional issuance costs in connection with private placement               (110)       (110)
Proceeds from sale of common stock through Employee Stock Purchase Plan               317       317
Proceeds from sale of common stock through Employee Stock Purchase Plan (in shares)     74,408                  
Issuance of common stock, net of issuance costs $ 3         $ 10,196       $ 10,199    
Issuance of common stock, net of issuance costs (in shares) 2,350,000                      
Vesting of restricted stock units, net of shares withheld and taxes paid               (395)       (395)
Vesting of restricted stock units (in shares)     140,004                  
Issuance of warrants in connection with debt financing               607       607
Stock-based compensation               3,647       3,647
Net loss                 (32,897)     (32,897)
Balance at the ending at Dec. 31, 2022     $ 12   $ 4     $ 132,939 $ (137,988)     $ (5,033)
Balance at the ending (in shares) at Dec. 31, 2022     11,823,445   4,313,406